세계의 동물 치료 및 진단 시장 보고서(2025년)
Animal Therapeutics And Diagnostics Global Market Report 2025
상품코드 : 1793395
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,527,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,434,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,341,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

동물 치료 및 진단 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년 연평균 복합 성장률(CAGR)은 6.8%를 나타내 670억 5,000만 달러로 성장할 전망입니다. 예측기간의 성장은 반려동물건강에 대한 지출 증가, 동물의료에서의 개별화의료, 바이오의약품의 확대, 혁신에 대한 규제당국의 지원에 기인하는 것으로 예측됩니다. 예측기간의 주요 동향으로는 생명공학의 진보, 디지털 헬스 통합, 예방의료에 중점화, 동물의 정밀의료, 동반 동물 치료제 수요 증가 등이 있습니다.

향후 5년간의 성장률 6.8%라고 하는 예측은 이 시장에 관한 전회의 예측으로부터 변경은 없습니다. 이 감소의 주요 원인은 미국과 다른 국가 간의 관세의 영향입니다. 독일에서 조달하는 일회용 바이오리액터 백과 단일클론항체 수지에 대한 관세는 차세대 생물제제의 제조 비용을 높일 우려가 있습니다. 또한 상호 관세와 무역 긴장 증가와 제한으로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 더 광범위하게 늘어날 것으로 보입니다.

반려동물 사육률의 급증은 당분간 동물 치료 및 진단 시장 성장을 이끌 것으로 예측됩니다. 반려동물을 가족의 일원으로 맞이하는 사람이 늘어남에 따라, 반려동물의 건강에 대한 의식과 관심이 높아지고, 동물의 치료나 진단에 대한 수요가 높아지고 있습니다. 반려동물 주인은 정기 검진 및 예방 조치를 포함하여 반려동물의 의료 관리에 투자하는 의지를 보여줍니다. 예를 들어, 2021년 미국 반려동물 용품 전문 온라인 소매업체인 Chewy Inc.는 약 97만 7,202마리의 반려동물 입양률을 보고하고 지난 6년간 최고의 입양률을 기록했습니다. 그 결과, 반려동물의 사육률의 상승이 동물 치료 및 진단 시장을 크게 뒷받침하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

KTH
영문 목차

영문목차

Animal therapeutics involve the application of medical procedures to improve the health of animals, while animal diagnostics focus on identifying and analyzing illnesses that impact animals.

The primary animal types for animal therapeutics and diagnostics include companion animals, cattle, pigs, and poultry. Companion animals are defined as tame or domestic-bred animals that can readily fulfill their social needs as companions in homes or through close daily interaction with humans. The diverse range of products in this domain includes animal diagnostics products, instruments, consumables, and animal therapeutics products, such as anti-parasitic drugs, antibiotics, anti-inflammatory drugs, and anesthetics.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are having a considerable impact on the veterinary healthcare sector, particularly in the supply of pharmaceuticals, medical devices, and animal care products. Increased duties on imported veterinary medicines, diagnostic equipment, surgical tools, and pet care supplies have driven up operational costs for veterinary clinics, animal hospitals, and livestock health providers, forcing them to either raise service charges or absorb reduced profit margins. The livestock and agricultural industries are facing similar pressures, as tariffs on feed additives, vaccines, and breeding equipment push up production costs and complicate animal health management. Furthermore, retaliatory tariffs in major export markets have weakened demand for U.S.-manufactured veterinary products, adding to revenue challenges. To navigate these headwinds, the sector must now focus on local sourcing, preventive healthcare strategies, and digital veterinary solutions to control costs while continuing to deliver quality animal care.

The animal therapeutics and diagnostics market research report is one of a series of new reports from The Business Research Company that provides animal therapeutics and diagnostics market statistics, including animal therapeutics and diagnostics industry global market size, regional shares, competitors with a animal therapeutics and diagnostics market share, detailed animal therapeutics and diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the animal therapeutics and diagnostics industry. This animal therapeutics and diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The animal therapeutics and diagnostics market size has grown strongly in recent years. It will grow from $48.99 billion in 2024 to $51.62 billion in 2025 at a compound annual growth rate (CAGR) of 5.4%. The growth in the historic period can be attributed to increased pet ownership, advancements in veterinary medicine, prevalence of animal diseases, government initiatives, globalization of veterinary services.

The animal therapeutics and diagnostics market size is expected to see strong growth in the next few years. It will grow to $67.05 billion in 2029 at a compound annual growth rate (CAGR) of 6.8%. The growth in the forecast period can be attributed to rising expenditure on pet healthcare, personalized medicine in veterinary care, expansion of biopharmaceuticals, regulatory support for innovation. Major trends in the forecast period include biotechnology advancements, digital health integration, increased focus on preventive healthcare, precision medicine for animals, rising demand for companion animal therapeutics.

The forecast of 6.8% growth over the next five years remains unchanged from the previous projection for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariffs on single-use bioreactor bags and monoclonal-antibody resins sourced from Germany threaten to inflate production costs for next-generation biologics. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in pet adoption rates is anticipated to drive the progression of the animal therapeutics and diagnostics market in the foreseeable future. As more individuals embrace pets as part of their families, heightened awareness and concern for their well-being have increased the demand for animal treatments and diagnostics. Pet owners demonstrate a willingness to invest in their pets' medical care, encompassing routine check-ups and preventive measures. For instance, in 2021, Chewy Inc., an online retailer in the US specializing in pet products, reported a record-breaking adoption rate of around 977,202 pets, marking the highest adoption rate in six years. Consequently, the escalating rate of pet adoptions significantly propels the animal therapeutics and diagnostics market.

The escalating prevalence of dermatological ailments is forecasted to fuel the expansion of the animal therapeutics and diagnostics market moving forward. Dermatological diseases encompass a wide spectrum of medical conditions impacting the skin, influenced by environmental factors, genetic predispositions, allergies, infections, and lifestyle alterations among animals. With pet owners increasingly prioritizing their animals' well-being and seeking veterinary interventions for dermatological concerns, there's a surge in demand for effective treatments. Moreover, heightened awareness regarding zoonotic diseases, transferable between animals and humans, accentuates the necessity for managing and treating skin conditions in animals. For example, as of October 2022, according to the British Broadcasting Corporation, India witnessed over 2.4 million animals affected by Lumpy Skin Disease, leading to the demise of more than 110,000 cattle. Consequently, the escalating burden of dermatological diseases significantly propels the growth of the animal therapeutics and diagnostics market.

Innovation stands as a pivotal trend gaining traction within the animal therapeutics and diagnostics market. Noteworthy enterprises within this sector are actively developing pioneering technologies to fortify their market presence. As an illustration, in December 2022, EKF Diagnostics, a UK-based company specializing in in vitro diagnostics, unveiled an updated version of the Lactate Scout analyzer tailored for veterinary applications. The enhanced analyzer offers species selection specifically designed for companion animals and cattle, rendering it suitable for implementation in both small and large animal healthcare practices.

Prominent entities operating within the animal therapeutics and diagnostics domain are spearheading innovations, notably telemedicine platforms catering to pet healthcare, in a bid to secure a competitive advantage. Telemedicine encompasses remote diagnosis, consultation, treatment, and monitoring of patients through telecommunication technologies such as video conferencing, phone calls, or secure messaging platforms. For instance, in June 2023, Cargill Inc., a US-based food corporation, introduced Zoonivet, a digital pet-care app. This Telehealth platform streamlines pet healthcare by facilitating video consultations between pet owners and qualified veterinarians, offering accessible and convenient primary pet care services. Zoonivet also plans to extend its services to include surgeries, home diagnostic services, medication, pet food, and pet boarding in key Indian markets.

In October 2023, Zomedica, a U.S.-based veterinary health company, announced its acquisition of Qorvo Biotechnologies LLC (QBT) for an undisclosed amount. This acquisition enables Zomedica to integrate Qorvo's innovative diagnostic technologies into its existing product portfolio, which includes advanced biosensing and diagnostic platforms that enhance the accuracy and speed of veterinary testing. Qorvo Biotechnologies LLC is based in the U.S. and focuses on developing point-of-care (POC) diagnostic solutions.

Major companies operating in the animal therapeutics and diagnostics market include Zoetis Inc., Boehringer Ingelheim Animal Health USA Inc., Virbac AH Inc., Ceva Animal Health Inc., Heska Corporation, IDEXX Laboratories Inc., bioMerieux Inc., Thermo Fisher Scientific Inc., Randox Laboratories Ltd., Bio-Rad Laboratories Inc., Bayer Animal Health LLC, Eli Lilly and Company, Merck & Co. Inc. Animal Health Division, Sanofi-Aventis Animal Health Inc., Elanco Animal Health Incorporated, BioNote Inc., IDvet, BASF Corporation, Koninklijke DSM N.V., Evonik Industries AG, MSD Animal Health, Vetoquinol S.A., Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, Kindred Biosciences Inc., Neogen Corporation, Abaxis Inc., QIAGEN N.V., Pfizer Animal Health, Norbrook Laboratories Limited

North America was the largest region in the animal therapeutics and diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global animal therapeutics and diagnostics market report during the forecast period. The regions covered in the animal therapeutics and diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the animal therapeutics and diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The animal therapeutics and diagnostics market include revenues earned by entities by providing services related to identifying and determining whether an animal has any viral, bacterial, parasitic, or other types of illnesses and related technologies such as clinical biochemistry, immunodiagnostics, molecular diagnostics, hematology, urinalysis, microbiology, and histopathology tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Animal Therapeutics And Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on animal therapeutics and diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for animal therapeutics and diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The animal therapeutics and diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Animal Therapeutics And Diagnostics Market Characteristics

3. Animal Therapeutics And Diagnostics Market Trends And Strategies

4. Animal Therapeutics And Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Animal Therapeutics And Diagnostics Growth Analysis And Strategic Analysis Framework

6. Animal Therapeutics And Diagnostics Market Segmentation

7. Animal Therapeutics And Diagnostics Market Regional And Country Analysis

8. Asia-Pacific Animal Therapeutics And Diagnostics Market

9. China Animal Therapeutics And Diagnostics Market

10. India Animal Therapeutics And Diagnostics Market

11. Japan Animal Therapeutics And Diagnostics Market

12. Australia Animal Therapeutics And Diagnostics Market

13. Indonesia Animal Therapeutics And Diagnostics Market

14. South Korea Animal Therapeutics And Diagnostics Market

15. Western Europe Animal Therapeutics And Diagnostics Market

16. UK Animal Therapeutics And Diagnostics Market

17. Germany Animal Therapeutics And Diagnostics Market

18. France Animal Therapeutics And Diagnostics Market

19. Italy Animal Therapeutics And Diagnostics Market

20. Spain Animal Therapeutics And Diagnostics Market

21. Eastern Europe Animal Therapeutics And Diagnostics Market

22. Russia Animal Therapeutics And Diagnostics Market

23. North America Animal Therapeutics And Diagnostics Market

24. USA Animal Therapeutics And Diagnostics Market

25. Canada Animal Therapeutics And Diagnostics Market

26. South America Animal Therapeutics And Diagnostics Market

27. Brazil Animal Therapeutics And Diagnostics Market

28. Middle East Animal Therapeutics And Diagnostics Market

29. Africa Animal Therapeutics And Diagnostics Market

30. Animal Therapeutics And Diagnostics Market Competitive Landscape And Company Profiles

31. Animal Therapeutics And Diagnostics Market Other Major And Innovative Companies

32. Global Animal Therapeutics And Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Animal Therapeutics And Diagnostics Market

34. Recent Developments In The Animal Therapeutics And Diagnostics Market

35. Animal Therapeutics And Diagnostics Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기